Tectonic Therapeutic on Track for Longest Losing Streak Since November 2021 -- Data Talk
Dow Jones2026/09/29 17:37Tectonic Therapeutic Inc (TECX) is currently at $23.16, down $0.35 or 1.47%
--Would be lowest close since March 2, 2026, when it closed at $23.00
--On pace for largest percent decrease since Sept. 25, 2026, when it fell 1.87%
--Currently down 11 consecutive days; down 22.03% over this period
--Longest losing streak since Nov. 19, 2021, when it fell for 12 straight trading days
--Worst 11-day stretch since the 11 days ending Sept. 10, 2026, when it fell 24.13%
--Down 22.63% month-to-date
--Up 11.05% year-to-date
--Down 96.34% from its all-time closing high of $632.40 on Sept. 26, 2018
--Up 47.64% from 52 weeks ago (Sept. 30, 2025), when it closed at $15.69
--Down 38.93% from its 52-week closing high of $37.93 on July 2, 2026
--Up 55.37% from its 52-week closing low of $14.91 on Oct. 7, 2025
--Traded as low as $22.54; lowest intraday level since March 3, 2026, when it hit $21.70
--Down 4.13% at today's intraday low
All data as of 1:29:50 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 29, 2026 13:37 ET (17:37 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
JPMorgan raises AbbVie target price to $300